Back

Association between reduced risk of gastrointestinal bleeding related to proton pump inhibitor use and subsequent all-cause death in patients with percutaneous coronary intervention

2 September 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (3) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Masanobu Ishii

Kumamoto University Hospital, Kumamoto (Japan)

8 More presentations in this session

Presentation thumbnail
Long-term clinical implications of routine follow-up coronary angiography of asymptomatic patients with long-duration diabetes mellitus after percutaneous coronary intervention in drug-eluting stent e
Doctor J. Jeong (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Prevalence, type, severity and determinants of sleep disordered breathing in acute myocardial infarction patients: the AMI-Sleep study
Doctor P. Balagny (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Comparison of the prognosis between complete and incomplete revascularization among moderate to severe chronic kidney disease patients with acute coronary syndrome
Doctor A. Phoksiri (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Prognostic value of combined myocardial performance index in patients with acute ST-elevation myocardial infarction
Doctor A. Kristosturyan (Syunik, AM)
Abstract Slides Video
Presentation thumbnail
Prognostic role of post-percutaneous coronary intervention quantitative flow ratio
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in percutaneous coronary intervention (3)

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Incidence and outcomes of new and persistent use of proton pump inhibitors following percutaneous coronary intervention: a retrospective population-based study
thumbnail
Congress Presentation
Proton pump inhibitors in myocardial infarction: safety paradox in Type 1 vs. Type 2---a multicenter retrospective cohort study
thumbnail
Congress Presentation
Safety and effectiveness of tegoprazan in patients treated with dual antiplatelet therapy after drug-eluting stent implantation for acute myocardial infarction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources